European Myocardial Infarction Market
European Myocardial Infarction Market Size, Share & Trends Analysis Report by Treatment Type (Pharmacological Treatment, Interventional Procedures, Adjunct & Supportive Care), by Medical Device Type (Left Ventricular Assist Device, Pacemaker, Catheters, Implantable Cardioverter Defibrillator, Others), by End-User (Hospitals, Specialty Centres, ASCs), and Forecast Period (2026–2035)
Industry Overview
European myocardial infarction market was valued at approximately $2.4 billion in 2025 and is projected to reach $3.8 billion by 2035, registering a CAGR of 4.7% during the forecast period. Myocardial infarction, commonly known as a heart attack, continues to be a major contributor to morbidity and mortality across Europe, driving the need for continuous innovation in diagnostic and therapeutic solutions. The market encompasses a broad range of medical devices such as pacemakers, implantable cardioverter defibrillators, catheters, and ventricular assist devices, along with pharmacological and interventional treatment approaches. Market growth is primarily fueled by the rising aging population, increasing prevalence of chronic conditions such as hypertension and diabetes, and sedentary lifestyles. Additionally, the growing preference for minimally invasive procedures and the expansion of advanced healthcare infrastructure are further accelerating the adoption of innovative cardiac care technologies across hospitals and specialized cardiac centers.
Technological advancements and product innovations by leading companies are playing a crucial role in strengthening the regional cardiac care ecosystem. In August 2025, GE HealthCare introduced the Vivid Pioneer, an AI-powered cardiovascular ultrasound system designed to enhance imaging speed, diagnostic accuracy, and clinical confidence through advanced 2D, 4D, and AI-enabled capabilities. Similarly, in October 2024, Medtronic received FDA approval for its Affera Mapping and Ablation System with Sphere-9 catheter, which utilizes advanced mapping and dual-energy ablation technology to improve precision in treating atrial fibrillation. While primarily focused on electrophysiology, such innovations indirectly support the management of ventricular arrhythmias associated with prior myocardial infarction. Collectively, these developments are enhancing early diagnosis, improving treatment outcomes, and driving the adoption of advanced myocardial infarction management solutions across Europe.
Market Dynamics
Minimally Invasive Interventions Strengthen MI Treatment Leadership
Interventional procedures continue to dominate the myocardial infarction market due to their proven ability to rapidly restore blood flow and lower mortality rates. Techniques such as angioplasty and stent placement are widely implemented across European healthcare systems. In September 2025, Abbott received Health Canada approval for its Esprit BTK Everolimus Eluting Resorbable Scaffold System, a novel dissolvable stent for treating blocked arteries. The device supports vessel healing and gradually dissolves, reducing the need for repeat interventions. Such advancements highlight the growing shift toward minimally invasive cardiac care solutions. Overall, continuous innovation in interventional devices is reinforcing treatment efficiency and improving outcomes in myocardial infarction management.
Advanced Cardiac Devices Driving MI Treatment Innovation
Cardiac device segment is witnessing strong growth, fueled by rising demand for long-term rhythm management solutions such as pacemakers and defibrillators. In January 2026, BIOTRONIK SE & Co. KG reported the first-in-human implantation of its LivIQ leadless pacemaker under clinical evaluation. The device introduces advanced atrioventricular synchronous pacing through far-field sensing technology. This innovation marks a significant step forward in leadless pacing systems. Such advancements are enhancing clinical outcomes and expanding treatment options for cardiovascular diseases, including myocardial infarction.
Market Segmentation
- Based on treatment type, the market is segmented into pharmacological treatment, interventional procedures, and adjunct & supportive care.
- Based on medical device type, the market is segmented into left ventricular assist device, pacemaker, catheters, implantable cardioverter defibrillator, and others.
- Based on end-user, the market is segmented into hospitals, specialty centres, and ASCs.
Hospitals Lead MI Care with Expanding Infrastructure in Europe
Hospitals continue to dominate the end-user segment due to their advanced infrastructure and high patient inflow. Growing investments in specialized cardiac care units and availability of skilled professionals further reinforce this leadership. In March 2025, Fresenius SE & Co. KGaA reported strong growth in its hospital division, Fresenius Helios, driven by rising patient volumes across Europe. The annual report highlighted expansion in hospital services and improvements in clinical efficiency. These developments enhance the capacity to manage complex cardiovascular conditions, including myocardial infarction. As a result, hospitals remain central to delivering comprehensive and high-quality cardiac care across the region.
Regional Outlook
European myocardial infarction market is further divided by countries, including the UK, Germany, Italy, Spain, France, Russia, and the rest of Europe.
Germany is the leading country in the market
Germany stands as a leading country in the European myocardial infarction market, driven by a high patient population and advanced healthcare infrastructure. The country benefits from strong adoption of cardiac medical devices and widespread use of interventional procedures. Its substantial healthcare expenditure and well-established cardiac care networks further reinforce market dominance. In February 2025, BIOTRONIK announced a strategic shift toward active implantable devices and digital healthcare solutions, including AI and remote monitoring. The company also agreed to divest its vascular intervention business to strengthen its core cardiac rhythm management portfolio. This initiative is expected to enhance innovation, operational efficiency, and patient outcomes across Europe’s cardiovascular care landscape.
Market Players Outlook
The major companies operating in the European myocardial infarction market include Johnson & Johnson, Abbott, Medtronic, Siemens Healthineers, and GE HealthCare, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In March 2026, Siemens Healthineers showcased AI-powered imaging and advanced interventional radiology solutions at the European Congress of Radiology (ECR) 2026 in Vienna. The innovations focus on enhancing diagnostic precision and workflow efficiency, including technologies relevant to cardiovascular care and coronary imaging. These developments support improved detection and treatment pathways for conditions such as myocardial infarction across Europe.
- In September 2025, Philips launched a smart telemetry platform for continuous cardiac monitoring, enabling enterprise-wide connectivity beyond bedside care. The solution integrates advanced data analytics and wearable monitoring to improve detection and management of cardiac conditions, including myocardial infarction. This innovation supports European hospitals in enhancing patient outcomes and operational efficiency through scalable, real-time cardiac care solutions.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the European myocardial infarction market.
- Based on the availability of data, information related to new protections and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- European Myocardial Infarction Market Sales Analysis – Treatment Type | Device Type | End User ($ Million)
- European Myocardial Infarction Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach Analytics
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key European Myocardial Infarction Market Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers of European Myocardial Infarction Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For European Myocardial Infarction Market: Impact Analysis
- Market Opportunities
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – European Myocardial Infarction Market Revenue and Share by Manufacturers
- European Myocardial Infarction Type Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Johnson & Johnson
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Abbott
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Medtronic
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Siemens Healthineers
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- GE HealthCare
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson & Johnson
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- European Myocardial Infarction Market Sales Analysis Treatment Type ($ Million)
- Pharmacological Treatment
- Interventional Procedures
- Adjunct & Supportive Care
- European Myocardial Infarction Market Sales Analysis Device Type ($ Million)
- Left Ventricular Assist Device
- Pacemaker
- Catheters
- Implantable Cardioverter Defibrillator
- Others
- European Myocardial Infarction Market Sales Analysis End User ($ Million)
- Hospitals
- Specialty Centres
- ASCs
- Regional Analysis
- European Non-Floating Dredging Hose Market Sales Analysis – Treatment Type | Device Type | End User | Country ($ Million)
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Company Profiles
- Admedes GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Aesculap AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Alvimedica
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Braun Melsungen AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Balton Sp. z o.o.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Berlin Heart GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biosensors International Group
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BIOTRONIK SE & Co. KG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cardionovum GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Corcym S.r.l.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Drägerwerk AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Esaote S.p.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Euroset S.p.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fresenius Medical Care AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Getinge AB
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- iVascular S.L.U.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Koninklijke Philips N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- LivaNova PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Oxford Instruments plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Schiller AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siemens Healthineers AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Smith & Nephew plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sorin Group
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Spacelabs Healthcare
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Xeltis B.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Admedes GmbH
1. European Myocardial Infarction Market Research and Analysis By Treatment Type, 2025-2035($ Million)
2. European Myocardial Infarction Pharmacological Treatment Market Research and Analysis, 2025-2035($ Million)
3. European Myocardial Infarction Interventional Procedures Market Research and Analysis, 2025-2035($ Million)
4. European Myocardial Infarction Adjunct & Supportive Care Market Research and Analysis, 2025-2035($ Million)
5. European Myocardial Infarction Market Research and Analysis By Device Type, 2025-2035($ Million)
6. European Myocardial Infarction Left Ventricular Assist Device Market Research and Analysis, 2025-2035($ Million)
7. European Myocardial Infarction Pacemaker Market Research and Analysis, 2025-2035($ Million)
8. European Myocardial Infarction Catheters Market Research and Analysis, 2025-2035($ Million)
9. European Myocardial Infarction Implantable Cardioverter Defibrillator Market Research and Analysis, 2025-2035($ Million)
10. European Myocardial Infarction Others Market Research and Analysis, 2025-2035($ Million)
11. European Myocardial Infarction Market Research and Analysis By End User, 2025-2035($ Million)
12. European Myocardial Infarction For Hospitals Market Research and Analysis, 2025-2035($ Million)
13. European Myocardial Infarction For Specialty Centres Market Research and Analysis, 2025-2035($ Million)
14. European Myocardial Infarction For ASCs Market Research and Analysis, 2025-2035($ Million)
15. European Myocardial Infarction Market Research and Analysis By Country, 2025-2035 ($ Million)
16. European Myocardial Infarction Market Research and Analysis By Treatment Type, 2025-2035($ Million)
17. European Myocardial Infarction Market Research and Analysis By Device Type, 2025-2035($ Million)
18. European Myocardial Infarction Market Research and Analysis By End User, 2025-2035($ Million)
1. European Myocardial Infarction Market Research and Analysis By Treatment Type, 2025 Vs 2035 ($ Million)
2. European Myocardial Infarction Pharmacological Treatment Market Research and Analysis, 2025 Vs 2035 ($ Million)
3. European Myocardial Infarction Interventional Procedures Market Research and Analysis, 2025 Vs 2035 ($ Million)
4. European Myocardial Infarction Adjunct & Supportive Care Market Research and Analysis, 2025 Vs 2035 ($ Million)
5. European Myocardial Infarction Market Research and Analysis By Device Type, 2025 Vs 2035 ($ Million)
6. European Myocardial Infarction Left Ventricular Assist Device Market Research and Analysis, 2025 Vs 2035 ($ Million)
7. European Myocardial Infarction Pacemaker Market Research and Analysis, 2025 Vs 2035 ($ Million)
8. European Myocardial Infarction Catheters Market Research and Analysis, 2025 Vs 2035 ($ Million)
9. European Myocardial Infarction Implantable Cardioverter Defibrillator Market Research and Analysis, 2025 Vs 2035 ($ Million)
10. European Myocardial Infarction Others Market Research and Analysis, 2025 Vs 2035 ($ Million)
11. European Myocardial Infarction Market Research and Analysis By End User, 2025 Vs 2035 ($ Million)
12. European Myocardial Infarction For Hospitals Market Research and Analysis, 2025 Vs 2035 ($ Million)
13. European Myocardial Infarction For Specialty Centres Market Research and Analysis, 2025 Vs 2035 ($ Million)
14. European Myocardial Infarction For ASCs Market Research and Analysis, 2025 Vs 2035 ($ Million)
15. UK Myocardial Infarction Market Size, 2025-2035 ($ Million)
16. France Myocardial Infarction Market Size, 2025-2035 ($ Million)
17. Germany Myocardial Infarction Market Size, 2025-2035 ($ Million)
18. Italy Myocardial Infarction Hose Market Size, 2025-2035 ($ Million)
19. Spain Myocardial Infarction Market Size, 2025-2035 ($ Million)
20. Russia Myocardial Infarction Market Size, 2025-2035 ($ Million)
21. Rest of Europe Myocardial Infarction Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
